Can routine blood tests detect nasopharyngeal cancer?

Nasopharyngeal cancer is diagnosed through nasopharyngeal endoscopy, and then a tissue is taken. According to the pathological analysis result, it is nasopharyngeal cancer. Usually, cancer cells can be seen in this case, which is called the gold standard and the only basis for diagnosis. It is impossible to diagnose nasopharyngeal cancer with a routine blood test. Nasopharyngeal cancer patients bleed more. Routine blood tests can indicate changes in blood indicators, which is beneficial for the observation of nasopharyngeal cancer patients during treatment. Nasopharyngeal cancer patients need to undergo routine blood tests, but nasopharyngeal cancer cannot be detected.

What is the best targeted drug for nasopharyngeal carcinoma?

Monoclonal antibody drugs include panitumumab, bevacizumab, cetuximab, nimotuzumab, etc. Monoclonal antibody targeted drugs usually need to be combined with chemotherapy to achieve the desired therapeutic effect, and these two side effects are not significant. Cetuximab may cause rash, and nimotuzumab can increase the response of radiotherapy and mucosa. Targeted drugs for nasopharyngeal carcinoma are mainly monoclonal antibody drugs and tyrosine kinase inhibitors.

Will an early symptom of nasopharyngeal cancer cause weight loss?

After being diagnosed with nasopharyngeal carcinoma, patients should seek timely treatment, actively cooperate with doctors, maintain a comfortable mood, participate in appropriate outdoor activities, enhance physical resistance and immunity, and reduce psychological stress. Nasopharyngeal carcinoma is a malignant tumor of the nasopharynx, and cancer is a wasting disease. The side effects of radiotherapy and chemotherapy can affect gastrointestinal function, so some patients may become emaciated.